ライフサイエンスコーパス: fresh frozen plasma

1 sate, which could be quenched by addition of fresh frozen plasma.

2 between CCP, intravenous immunoglobulin, and fresh frozen plasma.

3 and avoidance of preemptive transfusions of fresh frozen plasma.

4 2,058 nontrauma patients who did not receive fresh frozen plasma.

5 o did receive red blood cells in addition to fresh frozen plasma.

6 ion for patients receiving and not receiving fresh frozen plasma.

7 and nonleukoreduced red cells, platelets, or fresh-frozen plasma.

8 platelets (0.86 U vs. 0.24 U, p = 0.001) and fresh frozen plasma (0.68 U vs. 0.24 U, p = 0.015).

9 ts (0.1 [0.04] vs 1.9 U [4.5] p=0.0001), and fresh-frozen plasma (0.1 [0.07] vs 0.75 U [0.21] p=0.000

10 ut also the proportion of patients requiring fresh frozen plasma (21.1% vs. 48.3%, P = 0.025).

11 , and albumin dissolvent (68.1%) compared to fresh frozen plasma (28.6%) and sterile water (20.0%) (P

12 s of platelets (10.0 versus 6.6 U, P<0.012), fresh frozen plasma (4.8 versus 3.1 U, P<0.03), and cryo

13 platelets, 12.5 +/- 5.4 U vs. 8.6 +/- 6.4 U; fresh frozen plasma, 9.6 +/- 4.9 U vs. 4.9 +/- 3.6 U; an

14 Transfusions of platelets and fresh frozen plasma account for risk factors of ICU-acqu

15 The dose of fresh-frozen plasma administered was highly variable (me

16 ood products (red blood cells, platelets, or fresh frozen plasma) administered during transplantation

17 es, we found no association between ARDS and fresh frozen plasma administration.

18 ulopathy unresponsive to vitamin K requiring fresh-frozen plasma after the first 24 hours postresecti

19 ents who received a total of 46,101 units of fresh frozen plasma and 6,251 units of apheresis platele

20 The relative risk for transfusion of fresh frozen plasma and all infections was 2.99 (2.28-3.

21 ransfusion of high plasma volume components, fresh frozen plasma and apheresis platelets, from potent

22 tive RAR parameters predicted transfusion of fresh frozen plasma and cryoprecipitate with modest to h

23 ) of 65 received blood products (15 received fresh frozen plasma and eight received red blood cell co

24 Fresh frozen plasma and immunoglobulins were administere

25 analysis to evaluate the association between fresh frozen plasma and infectious complication, control

26 gnificant dose-response relationship between fresh frozen plasma and infectious complications (p = .0

27 The association between fresh frozen plasma and infectious complications remaine

28 ine concentrations, the amount of platelets, fresh frozen plasma and packed erythrocytes used, and th

29 nd anemia were corrected with transfusion of fresh frozen plasma and packed red blood cells.

30 Fresh frozen plasma and packed red cells were the most f

31 or the continued unbridled administration of fresh frozen plasma and platelets without objective evid

32 ave shown to reduce bleeding, transfusion of fresh frozen plasma and platelets, and possibly mortalit

33 ns to platelets is the highest compared with fresh frozen plasma and red blood cells.

34 When compared to fresh frozen plasma and regular convalescent plasma, pat

35 association was found between transfusion of fresh frozen plasma and ventilator-associated pneumonia

36 both platelets and coagulant products (e.g., fresh-frozen plasma and recombinant-activated factor VII

37 core analysis adjusting by use of platelets, fresh frozen plasma, and cryoprecipitate; and adjusting

38 h a 68%, 56%, and 58% reduction in platelet, fresh frozen plasma, and packed erythrocyte usage, respe

39 used patients, pooled platelet concentrates, fresh frozen plasma, and packed red cells collected usin

40 ed significantly less volume of packed RBCs, fresh frozen plasma, and platelet transfusion (p < 0.001

41 ng administration of packed red blood cells, fresh frozen plasma, and platelets in ratios approximati

42 from 7.8% to 92.8% for RBCs, 0% to 97.5% for fresh-frozen plasma, and 0.4% to 90.4% for platelets.

43 cluded sample type comparisons (whole blood, fresh/frozen plasma, and capillary finger prick) and pre

44 C1 inhibitor concentrates and fresh frozen plasma are available for acute intervention

45 an COVID-19 convalescent plasma and standard fresh frozen plasma are not different.

46 for whom prothrombin complex concentrates or fresh frozen plasma are, to date, the only option.

47 Tranexamic acid or virally inactivated fresh frozen plasma can be used for long-term prophylaxi

48 Transfused red cells, platelets, and fresh-frozen plasma can transmit West Nile virus.

49 zard ratio = 1.55 [1.09-2.20]; p = 0.01) and fresh frozen plasma (cause-specific hazard ratio = 1.38

50 s and infusing those with abnormalities with fresh-frozen plasma, coagulation factor concentrates, or

51 The value of fresh frozen plasma components, both standard and steril

52 gulation factor assays were compared between fresh frozen plasma, COVID-19 convalescent plasma, and p

53 Treatment with alteplase and fresh frozen plasma during NESLiP was associated with si

54 use of a combination of packed red cells and fresh-frozen plasma during surgery for congenital heart

55 ent between COVID-19 convalescent plasma and fresh frozen plasma, except for protein C antigen.

56 anticoagulation, and/or plasmapheresis with fresh-frozen plasma exchange, resolved TMA in most patie

57 ns for use of other blood components such as fresh frozen plasma (FFP) and platelet transfusions are

58 sought to define the overall utilization of fresh frozen plasma (FFP) and platelets and the impact o

59 tments utilized in clinical practice include fresh frozen plasma (FFP) and prothrombin complex concen

60 ) and is used to justify preprocedure use of fresh frozen plasma (FFP) and/or platelets (PLT).

61 re in the critically ill, data on the use of fresh frozen plasma (FFP) are limited.

62 duct, human polyclonal antibody, obtained as fresh frozen plasma (FFP) from a HPS survivor.

63 from Iraq supporting early aggressive use of fresh frozen plasma (FFP) in a 1:1 ratio to packed red b

64 plasma volume was removed and replaced with fresh frozen plasma (FFP) or with 50% FFP and 50% albumi

65 Because the administration of fresh frozen plasma (FFP) prevents gastrointestinal blee

66 The practice of a high transfusion ratio of fresh frozen plasma (FFP) to red blood cells (RBCs) has

67 We assessed the safety and efficacy of fresh frozen plasma (FFP) versus prothrombin complex con

68 amounts of packed red blood cells (RBCs) and fresh frozen plasma (FFP) were recorded during hospital

69 Fresh-frozen plasma (FFP) and intermediate purity factor

70 ross as a virally inactivated alternative to fresh-frozen plasma (FFP).

71 8 U blood products (red blood cells [RBCs] + fresh frozen plasma [FFP] + platelets) had a median (int

72 transfused with all three blood components (fresh frozen plasma [FFP], PLTs, and cryoprecipitate) ve

73 otal of 380 non-trauma patients who received fresh frozen plasma from 2004 to 2005 were compared with

74 ncreased risk of VTE, whereas transfusion of fresh frozen plasma had no effect.

75 ciation between infection and transfusion of fresh frozen plasma in patients who did not receive conc

76 e vWf-cleaving metalloprotease is present in fresh-frozen plasma, in cryoprecipitate-depleted plasma

77 The severe group required more fresh-frozen plasma intraoperatively than the mild group

78 Transfusion of fresh frozen plasma is associated with an increased risk

79 cation of these patients is critical so that fresh frozen plasma may be avoided.

80 nesthetized mice were transfused with murine fresh-frozen plasma (mFFP), PCC, mixtures of human vitam

81 o >1.5) or clinical (transfusion >2 units of fresh frozen plasma or >1 pack of platelets in 6 hours)

82 six allografts lost, despite treatment with fresh-frozen plasma or plasmapheresis.

83 red blood cells, platelet concentrates, and fresh frozen plasma over the routine storage time.

84 raoperative aVWS received significantly more fresh frozen plasma (P = .016) and fibrinogen concentrat

85 ion of packed red blood cells (p = .442) and fresh frozen plasma (p = .063) were not different betwee

86 Ratios of fresh frozen plasma:packed RBC and platelet:packed RBC.

87 high (>= 1:1) and medium (>= 1:2 and < 1:1) fresh frozen plasma:packed RBC ratio groups, respectivel

88 ess was developed to inactivate pathogens in fresh frozen plasma (PCT-FFP).

89 ive bleeding disorder treated by infusion of fresh-frozen plasma, plasma-derived FVII concentrates an

90 re frequent recurrences, and prescription of fresh-frozen plasma prophylaxis.

91 The administration of coagulation factors (fresh frozen plasma, prothrombin complex concentrates or

92 The mean packed red blood cells to fresh frozen plasma ratio changed from 2.6:1 during the

93 hemorrhagic shock; however, the exact RBC to fresh frozen plasma ratio is still unclear.

94 io-based transfusion (packed red blood cells:fresh frozen plasma ratio of 1:1 to 2:1) and were treate

95 Higher fresh frozen plasma ratios (> 1:2) were not associated w

96 Higher fresh frozen plasma ratios were associated with lower 24

97 use of a combination of packed red cells and fresh-frozen plasma (reconstituted blood) for priming of

98 r bias improved survival outcome with higher fresh frozen plasma: red blood cell ratios.

99 BEST PRACTICE ADVICE 6: The large volume of fresh frozen plasma required to reach an arbitrary inter

100 ction without prior PVE demonstrated a lower fresh frozen plasma requirement (P = 0.01), a lower peak

101 VE than the PVE group, as were postoperative fresh-frozen plasma requirements.

102 95% confidence interval [CI], 0.57 to 0.99), fresh frozen plasma (RR, 0.37; 95% CI, 0.21 to 0.64), an

103 Fresh-frozen plasma should be given for documented defic

104 ontinued, and treatment with plasmapheresis, fresh frozen plasma, steroids, and OKT3 was begun.

105 ence of reactions to platelets compared with fresh frozen plasma suggests that a platelet-related fac

106 Fresh frozen plasma-to-packed RBCs and platelets-to-pack

107 The benefits of higher ratios of fresh frozen plasma-to-packed RBCs and platelets-to-pack

108 with an odds ratio of infection per unit of fresh frozen plasma transfused equal to 1.039 (1.013-1.0

109 -test allowed comparison of average units of fresh frozen plasma transfused to patients with and with

110 [0-4] versus 1.1 units [0-3]; P = 0.21), or fresh frozen plasma transfusion requirements (0 unit [0-

111 rative packed red cells (r=0.28, P=.049) and fresh frozen plasma transfusions (r=0.42, P=.004), highe

112 RBC, platelet, and fresh frozen plasma transfusions collected up to 24 hour

113 e likely to have received RBC, platelet, and fresh frozen plasma transfusions.

114 nternational normalized ratios, 33% received fresh-frozen plasma transfusions during their intensive

115 Wide variation in fresh-frozen plasma treatment exists suggesting clinical

116 Fifty-one percent of fresh-frozen plasma treatments were to nonbleeding patie

117 of platelet units (4.3 vs. 1.7, p =.05) and fresh frozen plasma units (1.1 vs. 0.6, p =.08) also was

118 tests) and the transfusion (blood units and fresh frozen plasma units) during the operative period w

119 id infusion volume (6.1-3.2 L) and increased fresh frozen plasma use (3.2-10.1 U) (both P < .05) in t

120 apy and treatment with lactulose, vitamin K, fresh frozen plasma, ventilatory assistance, and intensi

121 unoglobulin (4 cases), interferon (3 cases), fresh frozen plasma with WNV IgG (2 cases), and ribaviri